Skip to main
RKDA
RKDA logo

Arcadia Biosciences (RKDA) Stock Forecast & Price Target

Arcadia Biosciences (RKDA) Analyst Ratings

Based on 3 analyst ratings
Strong Buy
Strong Buy 67%
Buy 33%
Hold 0%
Sell 0%
Strong Sell 0%

Bulls say

Arcadia Biosciences Inc. has demonstrated a positive trajectory in revenue growth, with 2024 revenue estimates rising to $5.4 million, an increase from previous forecasts, and a reported 2Q24 revenue of $1.3 million that exceeded expectations. Streamlined operations have resulted in significant cost savings, achieving $2 million in 2023 and projecting annual savings of $3 million to $4 million moving forward. Additionally, the company's expansion of its consumer brand offerings, particularly with the introduction of new flavors for Zola coconut water, positions Arcadia favorably in the growing better-for-you product segment, which constitutes nearly 20% of the market and continues to outpace traditional products.

Bears say

Arcadia Biosciences Inc. reported a significant revenue shortfall in its fourth quarter of 2023, generating only $0.8 million compared to an estimate of $1.8 million, and a steep decline from the prior year's revenue of $9.1 million. The company also faced a substantial net loss of $10.64 per share, reflecting operational challenges exacerbated by recent asset divestitures, particularly the loss of the GoodWheat franchise, which has diminished revenue visibility. Consequently, the company's full-year 2023 revenue of $5.3 million fell short of expectations, prompting a downward revision of future revenue estimates, further magnifying concerns regarding its financial stability and growth potential.

Arcadia Biosciences (RKDA) has been analyzed by 3 analysts, with a consensus rating of Strong Buy. 67% of analysts recommend a Strong Buy, 33% recommend Buy, 0% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Arcadia Biosciences and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Arcadia Biosciences (RKDA) Forecast

Analysts have given Arcadia Biosciences (RKDA) a Strong Buy based on their latest research and market trends.

According to 3 analysts, Arcadia Biosciences (RKDA) has a Strong Buy consensus rating as of Jun 16, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $8.17, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $8.17, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Arcadia Biosciences (RKDA)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.